Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Aspire Biopharma Holdings Inc ASBP

Alternate Symbol(s):  ASBPW

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for... see more

Current News (NDAQ:ASBP)

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition

ACCESS Newswire 1 day ago

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo

ACCESS Newswire 4 days ago

Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue

ACCESS Newswire 5 days ago

Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion

ACCESS Newswire 6 days ago

Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion

ACCESS Newswire March 19, 2026

Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director

ACCESS Newswire March 17, 2026

Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026

ACCESS Newswire March 12, 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack

ACCESS Newswire March 10, 2026

Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

ACCESS Newswire March 3, 2026

Opinion & Analysis (NDAQ:ASBP)

No current opinion is available.

Bullboard Posts (NDAQ:ASBP)

ASBP.....Looks ripe to me.....a break of $2.54 and it could

fill the gap above Big Fat Blue Breakout line at $2.52 Big Watch ; )
Iseneschal - January 20, 2026

ASBP...Post RS...NR this a.m ...On watch at $2.20

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic...
Iseneschal - January 20, 2026

ASBP....if it looks like a rock in water and it sinks

like a rock in water.......... it's is a rock !!!! Now at 14 cents LMFBO !
Iseneschal - November 11, 2025

ASBP.....read my previous post. The meeting was on Nov 4th

They voted on 2 proposals.......... Item 5.07 Submission of Matters to a Vote of Security Holders.   On November 4, 2025, at...
Iseneschal - November 11, 2025

ASBP......In case your wondering WTF is happening here

150 million shares are getting dumped on all you Chasers & FOMO's and the reason they are dumping is because there is a meeting...
Iseneschal - October 2, 2025